INDV logo

INDV
Indivior Plc

235
Mkt Cap
$4.16B
Volume
3M
52W High
$38.00
52W Low
$10.63
PE Ratio
20.57
INDV Fundamentals
Price
$38.51
Prev Close
$34.15
Open
$36.34
50D MA
$31.87
Beta
0.85
Avg. Volume
3.7M
EPS (Annual)
$1.64
P/B
-43.56
Rev/Employee
$1.48M
$4,748.64
Loading...
Loading...
News
all
press releases
VKTX Q1 Earnings Miss on Higher Phase 3 Development Costs
Viking Therapeutics posts a wider Q1 loss as R&D spend jumps on Phase III obesity drug work, while it advances VK2735 studies and preps oral late-stage study.
Zacks·2h ago
News Placeholder
More News
News Placeholder
Indivior Q1 Earnings Call Highlights
Indivior (NASDAQ:INDV) reported first-quarter 2026 results showing strong growth in U.S. SUBLOCADE and sharply higher profitability, while also outlining changes to its pipeline and detailing capital allocation actions taken during the quarter. Q1 results driven by SUBLOCADE growth and operating le...
MarketBeat·5h ago
News Placeholder
Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates
Indivior Pharmaceuticals Inc. (INDV) delivered earnings and revenue surprises of +50.78% and +18.01%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5h ago
News Placeholder
Indivior Plc. Bottom Line Climbs In Q1
(RTTNews) - Indivior plc. (INDV.L) announced a profit for its first quarter that Increases, from last year...
Nasdaq News: Markets·7h ago
News Placeholder
Teachers Retirement System of The State of Kentucky Invests $1.10 Million in Indivior PLC $INDV
Teachers Retirement System of The State of Kentucky bought a new position in shares of Indivior PLC (NASDAQ:INDV - Free Report) during the 4th quarter, according to its most recent 13F filing with...
MarketBeat·8h ago
News Placeholder
NTLA Falls 4% Despite Strong Phase III HAE Data, Initiates Rolling BLA
Intellia shares drop 4% despite phase III data meeting all endpoints. The company begins a rolling FDA filing.
Zacks·2d ago
News Placeholder
Indivior (NASDAQ:INDV) Trading 6% Higher - What's Next?
Indivior (NASDAQ:INDV) Shares Up 6% - Still a Buy...
MarketBeat·3d ago
News Placeholder
NVS SMA Drug Gets CHMP Backing, Malaria Drug Wins WHO Prequalification
Novartis secures CHMP backing for Itvisma in SMA and wins WHO nod for Coartem Baby, targeting critical gaps in rare disease and infant malaria care.
Zacks·3d ago
News Placeholder
Organon Shares Rally 16% in Premarket as Sun Pharma Announces Buyout
OGN stock soars as Sun Pharma strikes $11.75B all-cash deal, aiming to expand biosimilars reach and boost global pharma standing.
Zacks·3d ago
News Placeholder
NVO Reports Strong Phase III Diabetes Data for Children & Adolescents
Novo Nordisk reports phase III teen study success for oral semaglutide, showing strong HbA1c reduction and paving the way for the first oral GLP-1 for youth.
Zacks·6d ago
<
1
2
...
>

Latest INDV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.